Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-535.60M
↓ 137% below average
Average (9y)
$1.43B
Historical baseline
Range
High:$3.62B
Low:$-558.12M
CAGR
-0.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-535.60M | -114.8% |
| 2023 | $3.62B | +9.0% |
| 2022 | $3.32B | +41.8% |
| 2021 | $2.34B | -13.6% |
| 2020 | $2.71B | +130.4% |
| 2019 | $1.18B | -43.9% |
| 2018 | $2.10B | +695.8% |
| 2017 | $263.48M | +335.1% |
| 2016 | $-112.05M | +79.9% |
| 2015 | $-558.12M | - |